NDAORALCAPSULE, EXTENDED RELEASE
Approved
Dec 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
EQUETRO (carbamazepine) by Bausch Health is cytochrome p450 3a4 inducers [moa]. First approved in 2004.
Drug data last refreshed 2h ago · AI intelligence enriched 5h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EQUETRO is an extended-release oral capsule formulation of carbamazepine, a cytochrome P450 3A4 inducer used as a mood stabilizer. It is indicated for bipolar disorder and acts by modulating sodium channels and enhancing GABAergic neurotransmission. The product represents a reformulation strategy to optimize dosing convenience in psychiatric patients.
$0.001BPart D
LOE ApproachingDeclining
Declining sales and approaching loss of exclusivity signal consolidation of brand support and transition focus to retention vs. growth initiatives.
Mechanism of Action
Cytochrome P450 3A4 Inducers
Pharmacologic Class:
Mood Stabilizer
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood
Started Sep 2026
20 enrolled
Healthy
Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole
Started Apr 2026
28 enrolled
Healthy Participants
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Started Mar 2026
48 enrolled
Healthy Volunteers
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
Started Feb 2026
54 enrolled
Healthy Volunteer
To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants
Started Dec 2025
36 enrolled
HealthyVolunteer
Worked on EQUETRO at Bausch Health? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.